Na Gao
Kexue Road
Zhengzhou, 450001, China
Zhengzhou, 450001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications
Identification of replication factor C subunit 4 as a potential therapeutic target in esophageal squamous cell carcinoma based on bioinformatic analysis and machine learning.
Journal: Discover oncology
Published: February 24, 2026
A similarity-aware network with contrastive optimization for biomedical image segmentation.
Journal: BMC medical imaging
Published: February 23, 2026
Integrated network toxicology, machine learning, and bioinformatics analysis reveals sodium dehydroacetate-induced coagulation dysfunction in colorectal cancer.
Journal: Drug and chemical toxicology
Published: January 22, 2026
A novel CYP2E1 inhibitor, 4-Methyl-5-Acetylthiazole, mitigates LPS-induced acute lung injury by suppressing macrophage-mediated inflammation and preserving mitochondria.
Journal: Free radical biology & medicine
Published: January 22, 2026
Clinical discovery of anti-CYP2E1 autoantibodies and preclinical efficacy of a CYP2E1 inhibitor in rheumatoid arthritis.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: December 24, 2025
Impact of POR and cytochrome b5 variability on the genotype-phenotype discordance of CYP2A6 and CYP2D6: A quantitative analysis in Chinese human livers.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: December 17, 2025
CYP2E1 inhibitor Q11 shows potential in alleviating cisplatin-induced acute kidney injury via mitigating mitochondrial dysfunction and modulating NF-κB pathway.
Journal: Biochemical pharmacology
Published: November 05, 2025
4-Methyl-5-Acetylthiazole (Q11), a novel CYP2E1 inhibitor, has a protective effect on the hepatotoxicity induced by acetaminophen.
Journal: Bioorganic chemistry
Published: October 15, 2025
Anatabine: a substitute for the medicinal activity of nicotine.
Journal: European journal of pharmacology
Published: August 25, 2025
A Novel CYP2E1 Inhibitor, 4-Methyl-5-Acetylthiazole (Q11), Alleviates Obesity Via Modulating Adipose Inflammation and Mitochondrial Dysfunction.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 10, 2025
Dual effects of a new CYP2E1 inhibitor on gout: Anti-inflammatory actions and lowered uric acid levels.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: August 06, 2025
Chlorzoxazone-based One-Sample Method for Estimating In Vivo CYP2E1 Activity in Mice.
Journal: Current drug metabolism
Published: June 04, 2025
Last Updated: 09/26/2026